SCHEMBL3474804

SCHEMBL3474804

CN1CCOc2cc(Oc3ccc(C4CCNCC4O)cc3)ccc21.COCCCN1CCOc2ccc(COC3CCCNC3)cc21

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
REN P00797 10/20 0.34
GRM5 P41594 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3469145 0.92 REN (0.35) REN
SCHEMBL3272666 0.83 REN (0.40) REN
SCHEMBL8430844 0.83 REN (0.40) REN
SCHEMBL27740232 0.83 REN (0.43) RENGRM5
SCHEMBL3076669 0.79 REN (0.52) REN
SCHEMBL13030786 0.79 REN (0.52) REN
SCHEMBL8284795 0.78 REN (0.44) REN
SCHEMBL3076004 0.78 REN (0.44) REN
SCHEMBL13030760 0.78 REN (0.43) REN
SCHEMBL3079266 0.78 REN (0.43) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7799779-B2 Substituted piperidines as renin inhibitors NOVARTIS AG (CH) 2010-09-21 US disclosed
US-20090306064-A1 Substituted Piperidines as Renin Inhibitors NOVARTIS AG (CH) 2009-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306064-A1 Substituted Piperidines as Renin Inhibitors REN, AGTR1, ACE REN 1/4885GRM5 1532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.